| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |